Adipose-derived mesenchymal stem cells for the treatment of Amyotrophic Lateral Sclerosis. A phase I/II safety and efficacy clinical trial
M.J. Postigo-Pozo, Eduardo Agüera, Candela Caballero‐Eraso, G Navarro-Mascarell et al.
Journal
Frontiers in Neurology
Topics
Amyotrophic Lateral Sclerosis Research
article
Adipose-derived mesenchymal stem cells for the treatment of Amyotrophic Lateral Sclerosis. A phase I/II safety and efficacy clinical trial
M.J. Postigo-Pozo, Eduardo Agüera, Candela Caballero‐Eraso, G Navarro-Mascarell, María del Mar Macías-Sánchez, Juan Antonio Cabezas, José Tinoco-González, Maria Luisa García‐Martín, Gloria Carmona, Antonio Rodríguez-Acosta, Celedonio Márquez‐Infante, Laura Leyva, María Ángeles Peña-Toledo, Rafael Maldonado-Sánchez, Olga Fernández-López, Cecilia López Ramírez, Javier Padillo–Ruiz, Blanca Quijano-Ruiz, Luis Tallón‐Aguilar, Victoria Eugenia Fernández-Sánchez, Óscar Fernández-Fernández, Rosario Mata Alcázar-Caballero, Amador Valladares-Sánchez, MaLuisa Somoza-Ramírez, Virginia Reyes-Rodríguez, Giorgio Patrignani-Ochoa, María Ángeles Geniz-Clavijo
article en
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in NeurologyVol. 16
Institutions
Andalusian Health Service (ES), Hospital Universitario Virgen Macarena (ES), Hospital Regional Universitario de Málaga (ES), Hospital Universitario Reina Sofía (ES), Andalusian Centre for Nanomedicine and Biotechnology (ES), Hospital Universitario Virgen del Rocío (ES), Universidad de Málaga (ES)